Achieving a greater initial weight loss could potentially translate to greater long-term health benefits if that lower weight is successfully maintained through ongoing therapy

Seek immediate medical attention if cravings occur alongside : Symptoms of hypoglycemia (trembling, sweating, confusion, rapid heartbeat, dizziness) Severe nausea, vomiting, or abdominal pain Severe upper abdominal pain radiating to the back (possible pancreatitisstop medication immediately) Right upper quadrant abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Discuss at scheduled follow-up appointments : Persistent, intense cravings that interfere with daily functioning Unexplained weight gain or inability to lose weight despite medication adherence Symptoms of depression, anxiety, or disordered eating patterns Questions about medication dosage or administration Healthcare providers can assess whether medication dosage adjustments are appropriate, evaluate for potential hypoglycemia, and screen for underlying conditions that may contribute to cravings, such as insulin resistance or thyroid disorders

After injection, the medication reaches steady-state concentrations in approximately 4 to 5 weeks, with a half-life of about one week
Do not take RYBELSUS or OZEMPIC tablets with other liquids besides water [see Clinical Pharmacology (12.3)]
Wing RR, Lang W, Wadden TA, et al